Products with Digestants bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN3626 | Ceplignan |
| 1. (2S,3R)-Ceplignan and (2R,3S)-Ceplignan significantly enhances SERT activity, can used in treatments of neuropsychiatric and digestive disorders. | |
| BCN4280 | Specioside |
| 1. Specioside has analgesic activity. 2. Specioside has anti-dyspeptic and astringent activities. 3. Specioside has liver stimulating and wound healing activities. 4. Specioside exhibits potent antioxidant activity. 5. Specioside ameliorates oxidative stress and promotes longevity in Caenorhabditis elegans. | |
| BCN4430 | Methyl syringate |
| Methyl syringate is a specific and selective activator of hTRPA1, can regulate food intake and gastric emptying through a TRPA1-mediated pathway and, by extension, can contribute to weight suppression. Methyl syringate has a unique inhibitory activity toward aflatoxin production. Methyl syringate could be effective to suppress hypoxia-induced inflammation, it inhibits the hypoxic induction of COX-2 expression and cell invasion through TRPA1 activation. | |
| BCN5397 | Nystose |
| Nystose has antioxidant capacity. Nystose and 1-Kestose can modulate the intestinal Microorganisms flora, a high content of kestose and nestose in the diet can cause a decrease in ileal and cecal pH (to 5.42 and 5.49, respectively)of turkeys, which may promote digestion. | |
| BCN5989 | Fumaric acid |
| Fumaric acid is an intermediate in the citric acid cycle used by cells to produce energy in the form of adenosine triphosphate (ATP) from food; also a product of the urea cycle. Fumaric acid is used in systemic and topical treatment of psoriasis. Fumaric acid attenuates the eotaxin-1 expression in TNF-α-stimulated fibroblasts by suppressing p38 MAPK-dependent NF-κB signaling. | |
